Carbon ion radiation for elderly lung cancer patients
Part of Cancer, Injuries & trauma, Lungs & breathing clinical trials.
This trial tests carbon ion radiotherapy for adults 75 and older with locally advanced non-small cell lung cancer who cannot have surgery. The goal is to see if this precise type of radiation can treat the cancer effectively with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 75 years or older.
- You have non-small cell lung cancer that has spread to nearby lymph nodes but not to distant organs (stage IIb-IIIc).
- You are not healthy enough for surgery or you choose not to have surgery.
- Your organs are working well enough, including your lungs, heart, liver, kidneys, and blood counts.
- You have not had chest radiation or radioactive seeds placed in your body before.
- You do not have an uncontrolled infection, another active cancer, or conditions like a pacemaker that could interfere with treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to give radiation therapy (carbon ion boost) to people with advanced, inoperable lung cancer. The goal is to see if targeting the most aggressive parts of the tumor with a higher dose can improve outcomes.
This trial tests whether carbon ion radiation (high-energy targeted radiation) can control peripheral non-small cell lung cancer in people who are medically unable to have surgery. It may help shrink or stop tumor growth while limiting harm to nearby organs.
This trial tests a type of radiation called carbon ion therapy for people with thymus cancer that was not completely removed during surgery. The goal is to see if this treatment can target the remaining tumor cells safely and effectively.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
This trial tests a combination of chemotherapy, immunotherapy, and carbon ion radiation for people with non-small cell lung cancer that cannot be removed by surgery and has not spread to other parts of the body. It aims to see if this approach is safe and effective.
This trial tests a new type of radiation using carbon ions to treat large tumors in the chest that have come back or not responded to prior treatments. It aims to see if this therapy is safe and effective for people who have few options.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.